Skip to main content
NCBI home page
Chemistry Central Journal logoLink to Chemistry Central Journal
. 2017 Oct 16;11:105. doi: 10.1186/s13065-017-0335-8

A facile access and evaluation of some novel thiazole and 1,3,4-thiadiazole derivatives incorporating thiazole moiety as potent anticancer agents

Sobhi M Gomha 1,✉, Mohamad R Abdelaziz 2, Nabila A Kheder 1,3, Hassan M Abdel-aziz 4, Seham Alterary 5, Yahia N Mabkhot 5,✉
PMCID: PMC5643583  PMID: 29086869

Abstract

Background

Many heterocyclic compounds containing thiazole or 1,3,4-thiadiazole ring in their skeletons have been reported to possess various pharmacological activities especially anticancer activities.

Results

4-Methyl-2-phenylthiazole-5-carbohydrazide (2) was used as a synthon to prepare 2-(4-methyl-2-phenylthiazole-5-carbonyl)-N-phenylhydrazinecarbothioamide (3) and 2-(2-(4-methyl-2-phenylthiazole-5-carbonyl)hydrazono)-N′-phenylpropane hydrazonoyl chlorides 5a–c. In addition, thioamide 3 was used as starting material for preparation of a new series of thiadiazole derivatives via its reaction with hydrazonoyl chlorides 5a–c in dioxane using triethylamines as catalyst. In addition, a series of thiazole derivatives was synthesized by reaction of thioamide 3 with a number of α-halo compounds, namely, 3-chloropentane-2,4-dione (8) or 2-chloro-3-oxo-N-phenyl butanamide (10) phenacyl bromide 12 ethyl chloroacetate (14) in EtOH in the presence of triethylamine. The structures assigned for all the new products were elucidated based on both elemental analyses and spectral data and the mechanisms of their formation was also discussed. Moreover, the new products was evaluated in vitro by MTT assays for their anticancer activity against cell lines of Hepatocellular carcinoma cell line (HepG-2). The best result observed for compounds 7b (IC50 = 1.61 ± 1.92 (μg/mL)) and 11 (IC50 = 1.98 ± 1.22 (μg/mL)). The structure–activity relationships have been suggested based on their anticancer results.

Conclusions

A novel series of new pharmacophores containing thiazole moiety have been synthesized using a facile and convenient methods and evaluated as potent anticancer agents.graphic file with name 13065_2017_335_Figa_HTML.jpg

Keywords: Thiazoles, Thiadiazoles, Hydrazonoyl chlorides, Phenacyl bromide, Thioamide, Anticancer activity

Introduction

Identification of novel structure leads that may be of use in designing new, potent, selective and less toxic anticancer agents remains a major challenge for medicinal chemistry researchers. Compounds containing thiazole core have diverse biological activities as antihypertension, antifungal, antimicrobial, anti-inflammatory, antioxidant, antitubercular [1–7], and anticancer [8–12]. Also, thiazole ring present in many drugs such as Nizatidine, Abafungin, and Amiphenazole (Fig. 1).

Fig. 1.

Fig. 1

Open in a new tab

Some marketed drugs containing thiazole ring

Many biological activities were reported for the compounds containing 1,3,4-thiadiazole ring such as antituberculosis, anti-inflammatory, antidepressant and anxiolytic, antioxidant, anticonvulsants [13–17] and anticancer activities [18–20]. In addition, many drugs containing 1,3,4-thiadiazole ring are available in the market such as acetazolamide, methazolamide, and megazol (Fig. 2).

Fig. 2.

Fig. 2

Open in a new tab

Examples of drugs containing a 1,3,4-thiadiazole ring

In continuation of our studies dealing with the utility of hydrazonoyl halides for synthesis of various bioactive bridgehead nitrogen polyheterocycles [21–30], we wish to report herein a new facile synthesis of new heterocycles containing thiazole and 1,3,4-thiadiazole or two thiazole rings in one molecular frame. We anticipated that the synthesized compounds would have potent pharmacological activities.

Results and discussion

Chemistry

2-(4-Methyl-2-phenylthiazole-5-carbonyl)-N-phenylhydrazinecarbothioamide (3) [31] was prepared via reaction of 4-methyl-2-phenylthiazole-5-carbohydrazide (2) with phenyl isothiocyanate in EtOH (Scheme 1).

Scheme 1.

Scheme 1

Open in a new tab

Synthesis of thiazoles 2,3

The reaction of compound 2 with the appropriate hydrazonoyl chlorides 4a–c [32] in refluxing ethanol yielded the corresponding condensation product 5 (Scheme 2). The IR spectra of the latter products revealed a carbonyl and two NH absorption bands (see “Experimental” part). Their 1HNMR showed two D2O exchangeable signals of two NH protons in the regions δ 10.03–10.06 and δ 10.57–10.59 ppm. Also, their mass spectra confirmed the assigned structure 5 (Scheme 2). Treatment of thioamide derivative 3 with the appropriate hydrazonoyl halides of type 5a–c in refluxing EtOH containing TEA gave the corresponding thiadiazole derivatives 7a–c (Scheme 2). Their structures were elucidated on the basis of their spectral data and elemental analysis (see “Experimental”).

Scheme 2.

Scheme 2

Open in a new tab

Synthesis of thiadiazole derivatives 7a–c

Next, refluxing of compound 3 with 3-chloropentane-2,4-dione (8) or 2-chloro-3-oxo-N-phenyl butanamide (10) in EtOH in the presence of triethylamine afforded the thiazole derivatives 9 and 11, respectively (Scheme 3).The structure of compounds 9 and 11 were elucidated based on their elemental analysis and spectral data (see “Experimental”).

Scheme 3.

Scheme 3

Open in a new tab

Synthesis of thiazole derivatives 9, 11, 13 and 15

In a similar manner, thioamide 3 reacted with phenacyl bromide 12 under the same experimental condition to afford one isolable product 13 named as N′-(3,4-diphenylthiazol- 2(3H)-ylidene)-4-methyl-2-phenyl thiazole-5-carbohydrazide (Scheme 3). The structure of thiazole 13 was established based on its elemental analysis and spectral data (see “Experimental”).

Finally, thioamide derivative 3 reacted with ethyl chloroacetate (14) to afford thiazole 15 as showed in Scheme 3. Its IR spectrum showed absorption bands at v 3331 (NH), and 1726, 1648 (2C=O) cm−1. In addition, its 1HNMR spectrum showed singlet signal at δ 4.23 ppm due to the thiazolidinone (CH2) group.

Anticancer activity

The synthesized compounds were tested as anticancer agents against human Hepatocellular carcinoma cell line (HepG-2) using colorimetric MTT assay. We also included the well-known anticancer standard drug (Cisplatin) in the same assay to compare the potency of the synthesized compounds. The IC50 (the concentration of test compounds required to kill 50% of cell population) was determined (Table 1, Fig. 3).

Table 1.

The in vitro inhibitory activity of the tested compounds against tumor cell lines expressed as IC50 values (μg/mL) ± standard deviation from three replicates

Tested compounds IC50 (μg/mL) Tested compounds IC50 (μg/mL)
Cisplatin 1.43 ± 2.03 7c 7.51 ± 0.64
5a 22.3 ± 2.41 9 17.4 ± 0.73
5b 20.3 ± 3.70 11 1.98 ± 1.22
5c 57.2 ± 7.12 13 35.1 ± 10.8
7a 2.14 ± 3.54 15 3.31 ± 2.65
7b 1.61 ± 1.92
Open in a new tab

Fig. 3.

Fig. 3

Open in a new tab

Comparison of the IC50 of the new synthesized compounds against Cisplatin

The results of Table 1 revealed that the ascending order of the cytotoxic activity of the newly synthesized compounds towards the human Hepatocellular carcinoma cell line (HepG-2) were as follow: 5c < 13 < 5a < 5b < 9 < 7c < 15 < 7a < 11 < 7b (Fig. 4).

Fig. 4.

Fig. 4

Open in a new tab

The ascending order of the cytotoxic activity

From the data of Table 1, we concluded the following structure–activity relationships (SARs):

  • The thiazole ring is essential for the activity.

  • Less number of thiazole ring as in compounds 5a–c lead to drastic drop in activity.

  • 1,3,4-Thiadiazole ring is crucial for the cytotoxic activity.

  • Presence of methyl group (electron donating group) at position 4 of the phenyl ring in compound 7b increase its activity more than compound 7a.

  • The presence of the N-phenylcarboxamide group in compound 11 leads to increasing of its cytotoxic activity.

Experimental

Chemistry

General

Melting points were measured on an Electrothermal IA 9000 series digital melting point apparatus (Bibby Sci. Lim. Stone, Staffordshire, UK). IR spectra were measured on PyeUnicamSP 3300 and Shimadzu FTIR 8101 PC infrared spectrophotometers (Shimadzu, Tokyo, Japan) in potassium bromide discs. NMR spectra were measured on a Varian Mercury VX-300 NMR spectrometer (Varian, Inc., Karlsruhe, Germany) operating at 300 MHz (1HNMR) and run in deuterated dimethylsulfoxide (DMSO-d 6). Chemical shifts were related to that of the solvent. Mass spectra were recorded on a Shimadzu GCMS-QP1000 EX mass spectrometer (Tokyo, Japan) at 70 eV. Elemental analyses were measured by using a German made Elementarvario LIII CHNS analyzer. 2-(4-Methyl-2-phenylthiazole-5-carbonyl)-N-phenylhydrazinecarbothioamide (3) [31], and hydrazonoyl halides 4a–c [32] were prepared as reported in the respective literature.

Synthetic procedures

Synthesis of hydrazonoyl chlorides 5a–c

A mixture of 4-methyl-2-phenylthiazole-5-carbohydrazide (2) (2.33 g, 10 mmol) and the appropriate hydrazonoyl chlorides 4a–c (10 mmol) in ethanol (30 mL) was refluxed for 3–5 h (monitored through TLC).The resulting solid product was collected and recrystallized from the proper solvent to give the corresponding products 5a–c.

2-(2-(4-Methyl-2-phenylthiazole-5-carbonyl)hydrazono)-N′-phenylpropane hydrazonoyl chloride (5a)

Yellow solid; yield (84%); m.p. 188–190 °C (EtOH); IR (KBr) v 3440, 3316 (2NH), 3036, 2922 (CH), 1640 (C=O), 1599 (C=N) cm−1; 1H NMR (DMSO-d 6) δ 2.36 (s, 3H, CH3), 2.76 (s, 3H, CH3), 7.06–7.86 (m, 10H, ArH), 10.03 (s, br, 1H, D2O-exchangeable NH), 10.57 (s, br, 1H, D2O-exchangeable NH); MS m/z (%): 413 (M++2, 12), 411 (M+, 40), 375 (48), 202 (100), 174 (45), 71 (26). Anal. Calcd for C20H18ClN5OS (411.91): C, 58.32; H, 4.40; N, 17.00. Found: C, 58.19; H, 4.37; N, 16.88%.

2-(2-(4-Methyl-2-phenylthiazole-5-carbonyl)hydrazono)-N′-(p-tolyl)propane- hydrazonoylchloride (5b)

Yellow solid; yield (86%); m.p. 172–174 °C (EtOH); IR (KBr) v 3437, 3313 (2NH), 3041, 2917 (CH), 1679 (C=O), 1598 (C=N) cm−1; 1H NMR (DMSO-d 6) δ 2.24 (s, 3H, CH3), 2.34 (s, 3H, CH3), 2.77 (s, 3H, CH3), 7.08–7.99 (m, 9H, ArH), 10.06 (s, br, 1H, D2O-exchangeable NH), 10.59 (s, br, 1H, D2O-exchangeable NH); MS m/z (%) 427 (M++2, 10), 425 (M+, 33), 389 (26), 202 (81), 106 (100), 64 (66). Anal. Calcd for C21H20ClN5OS (425.93): C, 59.22; H, 4.73; N, 16.44. Found: C, 59.18; H, 4.65; N, 16.37%.

N′-(4-Chlorophenyl)-2-(2-(4-methyl-2-phenylthiazole-5-carbonyl)hydrazono) propane hydrazonoyl chloride (5c)

Yellow solid; yield (87%); m.p. 194–196 °C (DMF); IR (KBr) v 3434, 3319 (2NH), 3044, 2926 (CH), 1682 (C=O), 1593 (C=N) cm−1; 1H NMR (DMSO-d 6) δ 2.37 (s, 3H, CH3), 2.77 (s, 3H, CH3), 7.08–7.99 (m, 9H, Ar–H), 10.06 (s, br, 1H, D2O-exchangeable NH), 10.57 (s, br, 1H, D2O-exchangeable NH); MS m/z (%) 446 (M+, 8), 283 (14), 202 (39), 104 (46), 80 (100), 64 (90). Anal. Calcd for C20H17Cl2N5OS (446.35): C, 53.82; H, 3.84; N, 15.69. Found: C, 53.75; H, 3.79; N, 15.58%.

Synthesis of 1,3,4-thiadiazole derivatives 7a–c

A mixture of compound 3 (0.368 g, 1 mmol) and the appropriate hydrazonoyl chlorides 5a–c (1 mmol) in ethanol (20 mL) containing triethylamine (0.1 g, 1 mmol) was refluxed for 6 h. The formed solid product was filtered, washed with methanol, dried and recrystallized from the suitable solvents to give corresponding products 7a–c.

4-Methyl-N′-(1-(-5-(2-(4-methyl-2-phenylthiazole-5-carbonyl)hydrazono)-4-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)ethylidene)-2-phenylthiazole-5-carbohydrazide(7a)

Yellow solid; yield (74%); m.p. 162–164 °C (EtOH); IR (KBr) v 3421, 3307 (2NH), 3031, 2951 (CH), 1649 (C=O), 1596 (C=N) cm−1; 1H NMR (DMSO-d 6) δ 2.34 (s, 3H, CH3), 2.66 (s, 3H, CH3), 2.76(s, 3H, CH3), 6.97-8.14 (m, 15H, ArH), 10.18 (s, br, 1H, D2O-exchangeable NH), 11.17 (s, br, 1H, D2O-exchangeable NH); MS m/z (%) 650 (M+, 34), 526 (30), 416 (60), 358 (28), 104 (55), 64 (100). Anal. Calcd for C32H26N8O2S3 (650.80): C, 59.06; H, 4.03; N, 17.22. Found C, 58.94; H, 4.01; N, 17.07%.

4-Methyl-N′-(1-(5-(2-(4-methyl-2-phenylthiazole-5-carbonyl)hydrazono)-4-(p-tolyl)-4,5-dihydro-1,3,4-thiadiazol-2-yl)ethylidene)-2-phenylthiazole-5-carbohydrazide (7b)

Yellow solid; yield (72%); m.p. 149–151 °C (EtOH); IR (KBr) v 3422, 3328 (2NH), 3053, 2929 (CH), 1647 (C=O), 1597 (C=N) cm−1; 1H NMR (DMSO-d 6) δ 2.26 (s, 3H, CH3),2.35 (s, 3H, CH3), 2.65 (s, 3H, CH3), 2.76(s, 3H, CH3), 6.91–8.03 (m, 14H, ArH), 10.18 (s, br, 1H, D2O-exchangeable NH), 11.14 (s, br, 1H, D2O-exchangeable NH); MS m/z (%) 664 (M+, 35), 553 (60), 334 (19), 202 (65), 104 (85), 64 (100). Anal. Calcd for C33H28N8O2S3 (664.82): C, 59.62; H, 4.25; N, 16.85. Found C, 59.47; H, 4.17; N, 16.79%.

N′-(3-(4-Chlorophenyl)-5-(1-(2-(4-methyl-2-phenylthiazole-5-carbonyl)hydrazono)eth-yl)-1,3,4-thiadiazol-2(3H)-ylidene)-4-methyl-2-phenylthiazole-5-carbohydrazide (7c)

Yellow solid; yield (76%); m.p. 191–193 °C (Dioxane); IR (KBr) v 3424, 3312 (2NH), 3047, 2932 (CH), 1649 (C=O), 1599 (C=N) cm−1; 1H NMR (DMSO-d 6) δ 2.33 (s, 3H, CH3), 2.66 (s, 3H, CH3), 2.77(s, 3H, CH3), 6.90–8.11 (m, 14H, ArH), 10.13 (s, br, 1H, D2O-exchangeable NH), 11.19 (s, br, 1H, D2O-exchangeable NH); MS m/z (%) 686 (M++2, 8), 684 (M+, 26), 513 (53), 368 (39), 257 (17), 104 (25), 64 (100). Anal.Calcd for C32H25ClN8O2S3 (685.24): C, 56.09; H, 3.68; N, 16.35. Found C, 56.02; H, 3.58; N, 16.22%.

General procedure for the synthesis of thiazole derivatives 9, 11, 13, and 15

A mixture of compound 3 (0.368 g, 1 mmol) and the appropriate α-halo-compounds namely, 3-chloropentane-2,4-dione (8), 2-chloro-3-oxo-N-phenylbutanamide (10), 2-bromo-1-phenyl ethanone (12) and ethyl 2-chloroacetate (14) (1 mmol for each) in ethanol (20 mL) containing triethylamine (0.1 g, 1 mmol) was refluxed for 4–6 h. (monitored by TLC The solid product was filtered, washed with water, dried and recrystallized from the proper solvent to give the corresponding thiazole derivatives 9, 11, 13, and 15, respectively.

N′-(5-Acetyl-4-methyl-3-phenylthiazol-2(3H)-ylidene)-4-methyl-2-phenylthiazole-5-carbohydrazide (9)

Yellow solid; yield (78%); m.p. 155–157 °C (EtOH); IR (KBr) v 3432 (NH), 3036, 2993 (CH), 1695, 1648 (2C=O), 1590 (C=N) cm−1; 1H NMR(DMSO-d 6) δ 2.32 (s, 3H, CH3),2.46 (s, 3H, CH3), 2.77 (s, 3H, CH3), 6.91–7.86 (m, 10H, ArH), 10.61 (s, br, 1H, D2O-exchangeable NH); MS m/z (%) 448 (M+, 57), 246 (60), 176 (35), 104 (80), 77 (100). Anal.Calcd for C23H20N4O2S2 (448.56): C, 61.59; H, 4.49; N, 12.49. Found C, 61.48; H, 4.36; N, 12.37%.

4-Methyl-2-(2-(4-methyl-2-phenylthiazole-5-carbonyl)hydrazono)-N-3-diphenyl-2,3-dihydrothiazole-5-carboxamide (11)

Yellow solid; yield (79%); m.p. 182–84 °C (DMF); IR (KBr): v 3435, 3176 (2NH), 3030, 2928(CH), 1671, 1649 (2C=O), 1594 (C=N) cm−1; 1H NMR (DMSO-d 6) δ 2.36 (s, 3H, CH3),2.76(s, 3H, CH3), 6.97–7.73 (m, 15H, ArH), 10.46 (s, br, 1H, D2O-exchangeable NH), 11.72 (s, br, 1H, D2O-exchangeable NH); MS m/z (%) 525 (M+, 7), 447 (16), 334 (100), 200 (59), 77 (89). Anal.Calcd for C28H23N5O2S2 (525.64): C, 63.98; H, 4.41; N, 13.32. Found C, 63.84; H, 4.30; N, 13.28%.

N′-(3,4-Diphenylthiazol-2(3H)-ylidene)-4-methyl-2-phenylthiazole-5-carbohydrazide (13)

Yellow solid; yield (70%); m.p. 174–178 °C (EtOH); IR (KBr) v 3369 (NH), 3047, 2926(CH), 1648 (C=O), 1594 (C=N) cm−1; 1H NMR (DMSO-d 6) δ 2.75 (s, 3H, CH3), 7.03 (s, 1H, thiazole-H5), 7.35–8.02 (m, 15H, ArH), 10.73 (s, br, 1H, D2O-exchangeable NH); MS m/z (%) 468 (M+, 25), 334 (100), 200 (40), 104 (69), 64(65). Anal.Calcd for C26H20N4OS2 (468.59): C, 66.64; H, 4.30; N, 11.96. Found C, 66.55; H, 4.21; N, 11.79%.

4-Methyl-N′-(4-oxo-3-phenylthiazolidin-2-ylidene)-2-phenylthiazole-5-carbo- hydrazide (15)

Yellowish-white solid; yield (72%); m.p. 192–194 °C (Dioxane); IR (KBr) v 3331(NH), 3036, 2926 (CH), 1726, 1648 (2C=O), 1596 (C=N) cm−1; 1H NMR (DMSO-d 6) δ 2.65 (s, 3H, CH3), 4.23 (s, 2H, thiazolone-CH2), 7.40–7.88 (m, 10H, ArH), 10.82 (s, br, 1H, D2O-exchangeable NH); MS m/z (%) 408 (M+, 65), 334 (18), 202 (100), 104 (86), 64 (69). Anal.Calcd for C20H16N4O2S2 (408.50): C, 58.80; H, 3.95; N, 13.72. Found C, 58.68; H, 3.84; N, 13.64%.

Anticancer activity

The cytotoxic evaluation of the synthesized compounds was carried out at the Regional Center for Mycology and Biotechnology at Al-Azhar University, Cairo, Egypt according to the reported method [33].

Conclusions

We successfully synthesized a series of novel heterocycles containing thiazole and 1,3,4-thiadiazole rings by a facile and convenient method. The structure of the newly prepared compounds was established based on both elemental analysis and spectroscopic data. The anticancer activity of the synthesized compounds was measured and showed promising activity.

Authors’ contributions

SMG, NAK and YNM carried the literature study and designed synthetic schemes, MRA and SA contributed in the synthesis and purification of the compounds. All authors read and approved the final manuscript.

Acknowledgements

The authors extend their sincere appreciation to the Deanship of Scientific Research at the King Saud University for its funding this Prolific Research group (PRG-1437-29).

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abbreviations

HepG2

human hepatocellular carcinoma

EtOH

ethanol

m.p.

melting point

TEA

triethylamine

IR

infra-red

ATCC

American Type Culture Collection

TLC

thin layer chromatography

Contributor Information

Sobhi M. Gomha, Phone: +2100-164-9576, Email: s.m.gomha@gmail.com

Mohamad R. Abdelaziz, Email: Mohamedvac_75@yahoo.com

Nabila A. Kheder, Email: nabila.abdelshafy@gmail.com

Hassan M. Abdel-aziz, Email: dr_hassan1971@yahoo.com

Seham Alterary, Email: Sehasm2131@yahoo.com.

Yahia N. Mabkhot, Phone: +966-11-467-5898, Email: yahia@ksu.edu.sa

References

  • 1.Karegoudar P, Karthikeyan MS, Prasad DJ, Mahalinga M, Holla BS, Kumari NS. Synthesis of some novel 2,4-disubstituted thiazoles as possible antimicrobial agents. Eur J Med Chem. 2008;43:261–267. doi: 10.1016/j.ejmech.2007.03.014. [DOI] [PubMed] [Google Scholar]
  • 2.Gomha SM, Kheder NA, Abdelaziz MR, Mabkhot YN, Alhajoj AM. A facile synthesis and anticancer activity of some novel thiazoles carrying 1,3,4-thiadiazole moiety. Chem. Central J. 2017;11:25. doi: 10.1186/s13065-017-0255-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gomha SM, Abdel-Aziz HA. Synthesis of new heterocycles derived from 3-(3-methyl-1H-indol-2-yl)-3-oxopropanenitrile as potent antifungal agents. Bull Kor Chem Soc. 2012;33:2985–2990. doi: 10.5012/bkcs.2012.33.9.2985. [DOI] [Google Scholar]
  • 4.Kheder NA, Riyadh SM, Asiry AM. Azoles and bis-Azoles: synthesis and biological evaluation as antimicrobial and anti-cancer agents. Chem Pharm Bull. 2013;61:504–510. doi: 10.1248//cpb.c12-00939. [DOI] [PubMed] [Google Scholar]
  • 5.Sharma PK, Sawhney SN, Gupta A, Singh GB, Bani S. Synthesis and antiinflammatory activity of some 3-(2-thiazolyl)-1,2-benzisothiazoles. Indian J Chem. 1998;37B:376–381. [Google Scholar]
  • 6.Shih MH, Ying KF. Syntheses and evaluation of antioxidant activity of sydnonyl substituted thiazolidinone and thiazoline derivatives. Bioorg Med Chem. 2004;12:4633–4643. doi: 10.1016/j.bmc.2004.06.033. [DOI] [PubMed] [Google Scholar]
  • 7.Shiradkar M, Kumar GVS, Dasari V, Tatikonda S, Akula KC, Shah R. Clubbed triazoles: a novel approach to antitubercular drugs. Eur J Med Chem. 2007;42:807–816. doi: 10.1016/j.ejmech.2006.12.001. [DOI] [PubMed] [Google Scholar]
  • 8.Gomha SM, Khalil KD. A convenient ultrasound-promoted synthesis and cytotoxic activity of some new thiazole derivatives bearing a coumarin nucleus. Molecules. 2012;17:9335–9347. doi: 10.3390/molecules17089335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gomha SM, Salah TA, Abdelhamid AO. Synthesis, characterization and pharmacological evaluation of some novel thiadiazoles and thiazoles incorporating pyrazole moiety as potent anticancer agents. Monatsh Chem. 2015;146:149–158. doi: 10.1007/s00706-014-1303-9. [DOI] [Google Scholar]
  • 10.Gomha SM, Riyadh SM, Abbas IM, Bauomi MA. Synthetic utility of ethylidenethiosemicarbazide: synthesis and anti-cancer activity of 1,3-thiazines and thiazoles with imidazole moiety. Heterocycles. 2013;87:341–356. doi: 10.3987/COM-12-12625. [DOI] [Google Scholar]
  • 11.Gomha SM, Salah TA, Hassaneen HME, Abdel-aziz H, Khedr MA. Synthesis, characterization and molecular docking of novel bioactive thiazolyl-thiazole derivatives as promising cytotoxic antitumor drug. Molecules. 2016;21:1–17. doi: 10.3390/molecules21111532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gomha SM, Abdelaziz MR, Abdel-aziz HM, Hassan SA. Green synthesis and molecular docking of thiazolyl-thiazole derivatives as potential cytotoxic agents. MiniRev Med Chem. 2017;17:805–815. doi: 10.2174/1389557516666161223154539. [DOI] [PubMed] [Google Scholar]
  • 13.Oruç EE, Rollas S, Kandemirli F, Shvets N, Dimoglo AS. 1,3,4-thiadiazole derivatives. Synthesis, structure elucidation, and structure-antituberculosis activity relationship investigation. J Med Chem. 2004;47:6760–6767. doi: 10.1021/jm0495632. [DOI] [PubMed] [Google Scholar]
  • 14.Dawood KM, Abdel-Gawad H, Rageb EA, Ellithey M, Mohamed HA. Synthesis, anticonvulsant, and anti-inflammatory evaluation of some new benzotriazole and benzofuran-based heterocycles. Bioorg Med Chem. 2006;14:3672–3680. doi: 10.1016/j.bmc.2006.01.033. [DOI] [PubMed] [Google Scholar]
  • 15.Clerici F, Pocar D, Guido M, Loche A, Perlini V, Brufani M. Synthesis of 2-amino-5-sulfanyl-1,3,4-thiadiazole derivatives and evaluation of their antidepressant and anxiolytic activity. J Med Chem. 2001;44:931–936. doi: 10.1021/jm001027w. [DOI] [PubMed] [Google Scholar]
  • 16.Foroumadi A, Kiani Z, Soltani F. Antituberculosis agents VIII. Synthesis and in vitro antimycobacterial activity of alkyl alpha-[5-(5-nitro-2-thienyl)-1,3,4-thiadiazole-2-ylthio] acetates. Farmaco. 2003;58:1073–1076. doi: 10.1016/S0014-827X(03)00158-7. [DOI] [PubMed] [Google Scholar]
  • 17.Mullick P, Khan SA, Verma S, Alam O. Thiadiazole derivatives as potential anticonvulsant agents. Bull Kor Chem Soc. 2011;32:1011–1016. doi: 10.5012/bkcs.2011.32.3.1011. [DOI] [Google Scholar]
  • 18.Gomha SM, Kheder NA, Abdelhamid AO, Mabkhot YN. One pot single step synthesis and biological evaluation of some novel bis(1,3,4-thiadiazole) derivatives as potential cytotoxic agents. Molecules. 2016;21:1532. doi: 10.3390/molecules21111532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Gomha SM, Abdel-aziz HM, Khalil KD. Synthesis and SAR study of the novel thiadiazole-imidazole derivatives as new anti-cancer agents. Chem Pharm Bull. 2016;64:1356–1363. doi: 10.1248/cpb.c16-00344. [DOI] [PubMed] [Google Scholar]
  • 20.Gomha SM, Badrey MG, Edrees MM. Heterocyclization of a bis-thiosemicarbazone of 2,5-diacetyl-3,4-disubstituted-thieno[2,3-b]thiophene bis-thiosemicarbazones leading to bis-thiazoles and bis-1,3,4-thiadiazoles as anti-breast cancer agents. J Chem Res. 2016;40:120–125. doi: 10.3184/174751916X14537182696214. [DOI] [Google Scholar]
  • 21.Gomha SM. A facile one-pot synthesis of 6,7,8,9-tetrahydrobenzo [4,5]thieno [2,3-d]-1,2,4-triazolo[4,5-a]pyrimidin-5-ones. Monatsh Chem. 2009;140:213–220. doi: 10.1007/s00706-008-0060-z. [DOI] [Google Scholar]
  • 22.Abdelhamid AO, Gomha SM, Abdelriheem NA. Utility of 2-(5-methyl-1-phenyl-1H-pyrazol-4-yl)-2-oxo-N′-phenylaceto-hydrazonoyl bromide as precursor for synthesis of new functionalized heterocycles. Synth Commun. 2017;47:999–1005. doi: 10.1080/00397911.2017.1303071. [DOI] [Google Scholar]
  • 23.Abbas IM, Gomha SM, Elneairy MAA, Elaasser MM, Mabrouk BKA. Synthesis and characterization of some novel fused thiazolo[3,2-a]pyrimidinones and pyrimido[2,1-b][1,3]thiazinones. J Chem Res. 2015;39:719–723. doi: 10.3184/174751915X14474391581067. [DOI] [Google Scholar]
  • 24.Gomha SM, Riyadh SM. Synthesis of triazolo[4,3-b][1,2,4,5]tetrazines and triazolo[3,4-b][1,3,4]thiadiazines using chitosan as ecofriendly catalyst under microwave irradiation. Arkivoc. 2009;11:58–68. [Google Scholar]
  • 25.Abdallah MA, Riyadh SM, Abbas IM, Gomha SM. Synthesis and biological activities of 7-arylazo-7H-pyrazolo[5,1-c][1,2,4]triazolo-6(5H)-ones and 7-arylhydrazono-7H-[1, 2, 4]triazolo[3,4-b][1,3,4]thiadiazines. J Chin Chem Soc. 2005;52:987–994. doi: 10.1002/jccs.200500137. [DOI] [Google Scholar]
  • 26.Gomha SM, Badrey MG, Abdalla MM, Arafa RK. Novel Anti-HIV-1 NNRTIs Based on a pyrazolo[4,3-d]isoxazole backbone scaffold: design, synthesis and exploration of molecular basis of action. Med Chem Commun. 2014;5:1685–1692. doi: 10.1039/C4MD00282B. [DOI] [Google Scholar]
  • 27.Abbas IM, Riyadh SM, Abdallah MA, Gomha SM. A novel route to tetracyclic fused tetrazines and thiadiazines. J Heterocycl Chem. 2006;43:935–942. doi: 10.1002/jhet.5570430419. [DOI] [Google Scholar]
  • 28.Dawood KM, Gomha SM. Synthesis and anti-cancer activity of 1,3,4-thiadiazole and 1,3-thiazole derivatives having 1,3,4-oxadiazole moiety. J Heterocycl Chem. 2015;52:1400–1405. doi: 10.1002/jhet.2250. [DOI] [Google Scholar]
  • 29.Gomha SM, Riyadh SM. Multicomponent synthesis of novel penta-heterocyclic ring systems incorporating benzopyranopyridines scaffold. Synthesis. 2014;46:258–262. [Google Scholar]
  • 30.Gomha SM, Riyadh SM. Cellulose sulfuric acid as an eco-friendly catalyst for novel one-pot synthesis of pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5-ones. J Braz Chem Soc. 2015;26:916–923. [Google Scholar]
  • 31.Tiperciuc B, Zaharia V, Colosi I, Moldovan C, Crişan O, Pîrnau A, Vlase L, Duma M, Oniga O. Synthesis and evaluation of antimicrobial activity of some new hetaryl-azoles derivatives obtained from 2-aryl-4-methylthiazol-5-carbohydrazides and isonicotinic acid hydrazide. J Heterocycl Chem. 2012;49:1407–1414. doi: 10.1002/jhet.1060. [DOI] [Google Scholar]
  • 32.Shawali AS, Gomha SM. A New entry for short and regioselective synthesis of [1,2,4]triazolo[4,3-b][1,2,4]-triazin-7(1H)-one. Adv Synth Catal. 2000;342:599–604. [Google Scholar]
  • 33.Gomha SM, Riyadh SM, Mahmmoud EA, Elasser MM. Synthesis and anticancer activities of thiazoles, 1,3-thiazines, and thiazolidine using chitosan-grafted-poly(vinyl pyridine) as basic catalyst. Heterocycles. 2015;91:1227–1243. doi: 10.3987/COM-15-13210. [DOI] [Google Scholar]

Articles from Chemistry Central Journal are provided here courtesy of BMC

RESOURCES